National Stock Number
6505-01-566-8993
National Stock Number (NSN) 6505-01-566-8993, or NIIN 015668993, (japanese encephalitis vaccine) was assigned September 12, 2008 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.
There are 8 manufacturer part numbers associated with this NSN. One of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 4 suppliers. Today, 3 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 2 suppliers are deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years, with the most recent procurement date of May 24, 2012. There has been one contract issued for this part number, with 6 awards given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPM2DP09D0008, SPM2DP09D0008, SPM2DP09D0008, SPM2DP09D0008, SPM2DP09D0008. The total value of the awarded contracts has been US$ 12,039,721.67.
Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Apr 30, 2009, this NSN's acquisition method was noted as: Suitable for Competitive Acquisition. (Potential sources shall include dealers/distributors.) The Government has unlimited rights to the technical data, and the data package is complete. Valid AMCs: 1 and 2.
This NSN is assigned to Item Name Code (INC) 48491. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505015668993 does not contain precious metals.
This NSN is associated to Schedule B 3002200000: vaccines for human medicine. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325414: biological product (except diagnostic) manufacturing.
This information was last updated on Jun 01, 2025.